Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $29.6B bought by 1412 insiders at 808 companies
- $28.4B sold by 2631 insiders outside a trading plan
- $21.2B sold by 1966 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months, each insider's filings added up.
-
REBNReborn CoffeeJung Jae LimCEO$23.6B
-
RSGRepublic ServicesCascade Investment, L.l.c.10% owner, +1 joint filer$1.4B
-
NMMNavios Maritime PartnersAngeliki FrangouSee Remarks$847M
-
LENLennarBerkshire Hathaway Inc.10% owner, +1 joint filer$595M
-
JEFJefferiesSumitomo Mitsui Financial Group, Inc.Director$324M
-
CRBGCorebridge FinancialLife Insurance Co Nippon10% owner$289M
-
MAIRMadison Air SolutionsErnesto Bertarelli10% owner, +1 joint filer$219M
-
GPIGroup 1 AutomotiveConifer Management, L.L.C.10% owner$187M
-
KODKodiak SciencesBaker Bros. Advisors LPDirector, +5 joint filers$157M
-
SAFXXCF GlobalEEME Energy SPV I, LLC10% owner$142M
Biggest sales
Past 3 months, each insider's filings added up. Planned sales are marked.
-
IHTInnSuites Hospitality TrustJames F WirthCEO$7.8B
-
FANGDiamondback EnergySGF FANG Holdings, LP10% owner, +1 joint filer$3.7B
-
MDLNMedlineGIC Private Ltd10% owner, +2 joint filers$1.2B
-
BIRKBirkenstockJames Michael ChuDirector$1.1B
-
CHYMChime FinancialDST Global Advisors Ltd10% owner, +9 joint filers$1.1B
-
NVDANvidiaMark A StevensDirector$947M
-
JMKEJersey Mike's SubsBlackstone Holdings II L.P.10% owner, +4 joint filers$705M
-
AURAurora InnovationUber Technologies, Inc10% owner$654M
-
ALHAlliance LaundryBdt Capital Partners, LLCDirector, +6 joint filers$590M
-
ANETArista NetworksJayshree UllalCEO$510M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days, most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more
-
Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
MLTX insider trades
Every open-market buy and sale in MLTX, one row per filing, newest first
-
Kristian Reich Chief Scientific OfficerMLTXMoonLake ImmunotherapeuticsPlanned sale$22K 1,100 shares at $20.00 <0.1% of stakeTraded Jul 27 Filed Jul 29
-
Kristian Reich Chief Scientific OfficerMLTXMoonLake ImmunotherapeuticsPlanned sale$1M 52,448 shares at $20.02 1.9% of stakeTraded Jul 21–22 Filed Jul 23
-
Kristian Reich Chief Scientific OfficerMLTXMoonLake ImmunotherapeuticsPlanned sale$878K 43,700 shares at $20.09 1.6% of stakeTraded Jul 20 Filed Jul 21
-
Kristian Reich Chief Scientific OfficerMLTXMoonLake ImmunotherapeuticsPlanned sale$322K 16,105 shares at $20.01 0.6% of stakeTraded Jul 15 Filed Jul 20
-
Da Silva Jorge Santos CEOMLTXMoonLake ImmunotherapeuticsPlanned sale$2M 102,225 shares at $20.02 3.6% of stakeTraded Jul 9–10 Filed Jul 13
-
Da Silva Jorge Santos CEOMLTXMoonLake ImmunotherapeuticsPlanned sale$957K 47,775 shares at $20.03 1.6% of stakeTraded Jul 1 Filed Jul 2
-
Matthias Bodenstedt CFOMLTXMoonLake ImmunotherapeuticsPlanned sale$862K 39,120 shares at $22.04 3.4% of stakeTraded Jun 22 Filed Jun 23
-
Matthias Bodenstedt CFOMLTXMoonLake ImmunotherapeuticsPlanned sale$352K 17,876 shares at $19.67 1.5% of stakeTraded Jun 17–18 Filed Jun 18
-
Kristian Reich Chief Scientific OfficerMLTXMoonLake ImmunotherapeuticsPlanned sale$2.9M 150,000 shares at $19.01 5% of stakeTraded Jun 15–17 Filed Jun 17
-
Matthias Bodenstedt CFOMLTXMoonLake ImmunotherapeuticsPlanned sale$273K 13,653 shares at $20.02 1.2% of stakeTraded May 11 Filed May 13
-
Matthias Bodenstedt CFOMLTXMoonLake ImmunotherapeuticsPlanned sale$47K 2,426 shares at $19.56 0.2% of stakeTraded Apr 14 Filed Apr 16
-
Da Silva Jorge Santos CEOMLTXMoonLake ImmunotherapeuticsSale$2.8M 150,000 shares at $18.35 4.9% of stakeTraded Apr 10–13 Filed Apr 14
-
Bvf Partners L P Director, +9 joint filersMLTXMoonLake ImmunotherapeuticsSale$63M 3,750,000 shares at $16.79 78% of stakeTraded Mar 31 Filed Apr 2
-
Matthias Bodenstedt CFOMLTXMoonLake ImmunotherapeuticsBuy$99K 10,870 shares at $9.09 +1.8% to stakeTraded Oct 8, 2025 Filed Oct 9, 2025
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.